The Liver Meeting (AASLD), San Francisco13 NOV 2015
Presentations and PublicationsRead about publications and presentations made by Benitec's scientific team below. For details of Benitec's announcements to the ASX, read details in our Investor Centre.
Toxicology evaluation of TT-034 demonstrates durable expression in hepatic tissues without long term adverse effects on endogenous miRNA levels
In Vitro Characterization of the Activity of PF-05095808, a Novel Biological Agent for Hepatitis C Virus Therapy
Antimicrobial Agents and Chemotherapy. 2012; 56(3):1364-1375. doi:10.1128/AAC.05357-111 JAN 2012
Safe, Long-term Hepatic Expression of Anti-HCV shRNA in a Nonhuman Primate Model
Molecular Therapy. 2012; 20(9):1737-1749. doi:10.1038/mt.2012.1191 JAN 2012